NGS BRCA1 & 2 (Somatic) Assay

The NGS BRCA1 & 2 (Somatic) Assay for the detection of BRCA somatic and germline mutations from formalin-fixed, paraffin-embedded (FFPE) tissue has been widely adopted in molecular pathology laboratories across the world. The Assay can now detect large InDels and exon or whole gene deletion or duplication events in BRCA1 and BRCA2 gene. Clinical Indications: Breast, Ovarian, Prostate Cancer.

Note: Genetic counseling can be provided. If interested, please send the request to this email id: [email protected]

Disclaimer: In no event shall the liability of TATA 1MG exceed the amount of actual cost of test charges incurred by the customer as stated on the invoice issued by Tata 1mg.